AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...
Plants are constantly exposed to a wide array of biotic and abiotic stresses in their natural environments, posing ...
What if the thermal noise that hinders the efficiency of both classical and quantum computers could, instead, be used as a ...
Overview AI medical diagnosis can recognize disease patterns even before symptoms worsenPredictive healthcare models delve into risk factors over the long termM ...
Glucose dysregulation may drive cerebral small vessel disease progression through microstructural brain damage, according to ...
Researchers at the Lawrence Berkeley National Laboratory have developed a design and training framework ...
Alnylam is broadening its position in the area of RNA interference (RNAi) gene-silencing therapies for cardiovascular diseases via a partnership with Tenaya Therapeutics, claiming rights to use the ...
Researchers from Duke Health and the University of Minnesota recently discovered that measuring specific tiny genetic ...
Agreement Combines Tenaya’s Expertise in Identification and Validation ofGenetic Heart Disease Targets with Alnylam’s Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 ...
Researchers have developed a diagnostic panel that identifies cognitive decline by analyzing how blood proteins fold. This ...
Tenaya leverages “human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with high-throughput in vitro screening, imaging analysis, and machine learning algorithms” to identify new ...